Mycoparasitic and fungicolous fungi are those which attack and colonize other fungal species, and often cause damage to the host fungi. In many cases, at least part of this damage appears to be caused by antifungal metabolites. In spite of such observations, these commonly occurring fungi remain relatively unexplored from a chemical standpoint. As a part of our ongoing studies of mycoparasitic and fungicolous fungi as sources of new antifungal metabolites, 1-3 a fungicolous isolate of Epicoccum purpurascens (MYC 1097 = NRRL 37031) was selected for investigation. Epicoccum purpurascens Ehrenb. Ex Schlecht (syn. E. nigrum Link) has been recorded as a colonist of decaying basidiocarps of larger fungi 4 and has been studied as an antagonist that produces antibiotics [5] [6] [7] [8] and/or parasitizes the mycelium of fungal pathogens of crop plants. [9] [10] [11] [12] Studies of an organic extract from cultures of E. purpurascens MYC 1097 afforded two new metabolites: 7-methoxy-4-oxo-chroman-5-carboxylic acid methyl ester (1) and 1,3-dihydro-5-methoxy-7-methylisobenzofuran (2). The known compounds 4,5,6-trihydroxy-7-methyl-3H-isobenzofuran-1-one (3) and 1,3-dihydro-4,6-dihydroxy-7-methylisobenzofuran (4) were also obtained. Details of these studies are presented here.
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The EtOAc extract of solid-substrate fermentation cultures of E. purpurascens was fractionated by Sephadex LH-20 column chromatography. Chromanone metabolite 1 was obtained from the least polar fraction by subsequent silica gel column chromatography. HPLC separation of more polar fractions led to the isolation of the isobenzofuran derivatives 2-4.
The molecular formula of compound 1 was determined to be C 12 . Analysis of 13 C NMR δ-values and HMQC data confirmed the presence of a 1,3-dioxygenated, tetrasubstituted benzene ring. These results suggested that compound 1 has a disubstituted chromanone structure. The locations of the substituents were established primarily on the basis of HMBC and NOE data ( Figure 1 ). An HMBC correlation of H 3 -11 to C-7 established the position of the aryl methoxy group, while a correlation of H 3 -10 with carboxy carbonyl C-9 indicated the presence of a methyl ester unit. Correlations of the protons of the -OCH 2 CH 2 -unit with the carbonyl at δ c 189.0 and two adjacent aryl carbons (C-4a and C-8a) as shown in Figure 1 required formation of a pyranone ring fused to the benzenoid moiety. NOE correlations of H 3 -11 with both H-6 and H-8, and of H 3 -10 with H-6, supported the regiochemistry shown in 1, and completed assignment of the structure. Chromanone derivatives have been isolated from a variety of fungi 13 and plants. 14 Among the known naturally occurring chromanones, nearly all have alkyl substituents at the C-2 or C-3 position. 5,7-Dihydroxy-8-methoxy-4-chromanone, previously isolated from a plant source, 15 appears to be the only prior example that is unsubstituted in the pyranone ring. To our knowledge, compound 1 is the first fungal chromanone which bears no substituent at either the C-2 or C-3 position.
Known compound 4, originally reported as a potent antioxidant metabolite from Aspergillus terreus, was isolated as a relatively major constituent of the extract, and identified C NMR data very similar to those of 4. A 2.2-Hz homobenzylic coupling constant between the two sets of methylene protons (H 2 -1 and H 2 -3 was also observed, which is consistent with this type of dihydrobenzofuran structure. 17 The only difference was the presence of an additional methoxy group (δ H 3.73; δ C 61.0) in place of one of the phenolic OH groups. This was consistent with the molecular formula C 10 H 12 O 4 , which was established by HREIMS. The methoxy group was located at C-5 on the basis of HMBC and 1D NOE data. An HMBC correlation of H 3 -9 to the most upfield oxygen-substituted aromatic carbon (C-5), as well as NOE interactions between H 3 -9 and both phenolic OH signals, enabled placement of the methoxy group at C-5. The location of the aryl methyl group at C-7 was also supported by HMBC and NOE analysis. Compound 2 has not been previously reported, but the 4,5-dimethoxy analog has been described from another fungal source. 18 The 1 H NMR spectrum of compound 3 (C 9 H 8 O 5 based on HREIMS) contained only two singlets at δ H 5.11 and 2.41, along with three broad OH peaks (using DMSO-d 6 as the NMR solvent). This observation, together with analysis of 13 C NMR data, suggested that 3 is an oxidized version of 4 containing carboxy carbonyl group in place of one methylene unit with, to give an isobenzofuranone structure. The identity of this compound was confirmed as shown in 3 by spectral analysis. This metabolite has been recently encountered as a metabolite of a marine isolate of Epicoccum sp., and was assigned the common name epicoccone. 19 Other isobenzofuranones 20 and isobenzofuran acetal 21 metabolites, which have structural similarities to 2-4, have been previously isolated as metabolites from Aspergillus spp.
Despite the source of the isolate and the prior reports of antibiotic activity for metabolites and extracts of E. purpurascens, standard disk assays for antifungal effects against Aspergillus flavus NRRL 6541 and Fusarium verticillioides NRRL 25457 revealed that none of the four compounds isolated showed significant activity at levels up to 200 μg/disk. Biosynthetically, compounds 1-4 are all presumed to be derived from the polyketide pathway, with 1 constructed from five acetate units, and 2-4 arising from four acetate units.
In conclusion, chemical studies of an organic extract of the fungicolous fungus Epicoccum purpurascens (MYC-1097 = NRRL 37031) led to isolation of two new metabolites 1, 2 and two known compounds 3 and 4. The structures of these compounds were elucidated on the basis of NMR and MS data.
Experimental Section
General experimental procedures. 1 H and 13 C NMR spectra were recorded with a Bruker DRX-400 instrument. HMBC and HMQC spectra were recorded at 600 MHz ( Extraction and isolation. The culture was incubated on rice (2 × 50 g) at 25 °C for 30 days and extracted with EtOAc (3 × 500 mL). The resulting EtOAc extract (1.5 g) was partitioned between CH 3 CN and hexane to obtain a CH 3 CN-soluble mixture (1.1 g) that was fractionated using a Sephadex LH-20 column (110 g) eluting with 1:1 CH 2 Cl 2 -acetone to provide 20 fractions. Non-polar fraction 2 (4.5 mg) was further purified by passing through a small silica gel pad with 3:2 hexane-EtOAc to remove trace impurities to afford compound 1 (2.2 mg; R f 0.24 in 3:2 hexaneEtOAc). Reversed-phase HPLC separation of fraction 11 (12 mg) eluting with a 30-100% CH 3 CN in H 2 O over 30 min yielded compound 2 (2.7 mg). Silica gel column chromatography of fraction 15 (58 mg) using 10:1 CHCl 3 -MeOH provided compound 4 (37 mg, R f 0.34 in 9:1 CHCl 3 -MeOH). Silica gel column chromatography of fraction 16 (25 mg) using 9:1 CHCl 3 -MeOH provide a subfraction (8.5 mg), which was further purified by reversed-phase HPLC eluting with a 30-100% CH 3 
